Inter-observer agreement on biological treatment decision for severe asthma.
M. Boulay (Quebec, Canada), R. Beaulé (Quebec, Canada), L. Boulet (Quebec, Canada), K. Godbout (Quebec, Canada), D. Price (Singapore, Singapore), A. Côté (Quebec, Canada)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2385
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Boulay (Quebec, Canada), R. Beaulé (Quebec, Canada), L. Boulet (Quebec, Canada), K. Godbout (Quebec, Canada), D. Price (Singapore, Singapore), A. Côté (Quebec, Canada). Inter-observer agreement on biological treatment decision for severe asthma.. 2385
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|